Eddy Kim is a managing director in the firm’s strategic advisory business focused on the biopharma sector.
Since joining Evercore in 2008, Mr. Kim has been involved in numerous strategic and financing transactions, including advising Nestlé on its sale of Nestlé Skin Health to EQT and ADIA; Takeda Pharmaceutical Company on its acquisition of Shire; and Sanofi-Aventis on its purchase of Genzyme.
Mr. Kim leads the firm’s internal training program for newly hired analysts and associates each summer.
He graduated from the Carroll School of Management at Boston College with a B.S. in finance and marketing.